Open Access

[Corrigendum] Tumor‑penetrating peptide fused EGFR single‑domain antibody enhances radiation responses following EGFR inhibition in gastric cancer

  • Authors:
    • Fuzhi Ji
    • Huizi Sha
    • Fanyan Meng
    • Anqing Zhu
    • Naiqing Ding
    • Hang Zhang
    • Hui Xu
    • Hanqing Qian
    • Lixia Yu
    • Qizhan Liu
    • Baorui Liu
  • View Affiliations

  • Published online on: November 4, 2020     https://doi.org/10.3892/or.2020.7834
  • Pages: 404-405
  • Copyright : © Ji et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

January-2021
Volume 45 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ji F, Sha H, Meng F, Zhu A, Ding N, Zhang H, Xu H, Qian H, Yu L, Liu Q, Liu Q, et al: [Corrigendum] Tumor‑penetrating peptide fused EGFR single‑domain antibody enhances radiation responses following EGFR inhibition in gastric cancer. Oncol Rep 45: 404-405, 2021
APA
Ji, F., Sha, H., Meng, F., Zhu, A., Ding, N., Zhang, H. ... Liu, B. (2021). [Corrigendum] Tumor‑penetrating peptide fused EGFR single‑domain antibody enhances radiation responses following EGFR inhibition in gastric cancer. Oncology Reports, 45, 404-405. https://doi.org/10.3892/or.2020.7834
MLA
Ji, F., Sha, H., Meng, F., Zhu, A., Ding, N., Zhang, H., Xu, H., Qian, H., Yu, L., Liu, Q., Liu, B."[Corrigendum] Tumor‑penetrating peptide fused EGFR single‑domain antibody enhances radiation responses following EGFR inhibition in gastric cancer". Oncology Reports 45.1 (2021): 404-405.
Chicago
Ji, F., Sha, H., Meng, F., Zhu, A., Ding, N., Zhang, H., Xu, H., Qian, H., Yu, L., Liu, Q., Liu, B."[Corrigendum] Tumor‑penetrating peptide fused EGFR single‑domain antibody enhances radiation responses following EGFR inhibition in gastric cancer". Oncology Reports 45, no. 1 (2021): 404-405. https://doi.org/10.3892/or.2020.7834